Joannes van Krieken - Publications#

(Co)author of more than 400 peer reviewed articles (cited more than 13000 times; Hirsch-index 69) and several chapters in books, including Medical Oncology (Dutch, editor), Pathology (Dutch), Histology for Pathologists (Spleen), Oxford textbook of Medicine (Gastric Cancer), WHO-classification for Hematological Malignancies (Lymphoproliferations in immune deficiency), WHO-classification of Gastrointestinal tumors (Lymphomas, premalignant lesions), Paedriatic Hematopathology (Lymphomas in immunodeficiency); IARC book on Prognostic factors (gastric cancer); ESMO handbook on cancer diagnosis; Knowles Neoplastic Hematopathology

5 recent papers:

1: Nagtegaal ID, West NP, van Krieken JH, Quirke P. Pathology is a necessary and informative tool in oncology clinical trials. J Pathol. 2014;232:185-9.

2: van den Brand M, van Krieken JH. Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review. Haematologica. 2013;98:1003-13.

3: de Voer RM, Geurts van Kessel A, Weren RD, Ligtenberg MJ, Smeets D, Fu L, Vreede L, Kamping EJ, Verwiel ET, Hahn MM, Ariaans M, Spruijt L, van Essen T, Houge G, Schackert HK, Sheng JQ, Venselaar H, van Ravenswaaij-Arts CM, van Krieken JH, Hoogerbrugge N, Kuiper RP. Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer.
Gastroenterology. 2013;145:544-7.

4: Nagtegaal ID, van Krieken JH. Colorectal cancer: Is the new era of colorectal cancer classification finally here? Nat Rev Gastroenterol Hepatol. 2013;10:391-3.

5: van Krieken JH, Siebers AG, Normanno N; Quality Assurance for Molecular Pathology group. European consensus conference for external quality assessment in molecular pathology. Ann Oncol. 2013;24:1958-63.

5 papers marking the career

1: van Krieken JH, Langerak AW, Macintyre EA, Kneba M, Hodges E, Sanz RG, Morgan GJ, Parreira A, Molina TJ, Cabecadas J, Gaulard P, Jasani B, Garcia JF, Ott M, Hannsmann ML, Berger F, Hummel M, Davi F, Bruggemann M, Lavender FL, Schuuring E, Evans PA, White H, Salles G, Groenen PJ, Gameiro P, Pott Ch, Dongen JJ. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007;21:201-6.

2: Schraders M, Pfundt R, Straatman HM, Janssen IM, van Kessel AG, Schoenmakers, EF, van Krieken JH, Groenen PJ. Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization. Blood. 2005;105:1686-93.

3: Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH; Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002 ;20:1729-34.

4: de Boer CJ, Schuuring E, Dreef E, Peters G, Bartek J, Kluin PM, van Krieken JH. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood. 1995;86:2715-23.

5: Medeiros LJ, Van Krieken JH, Jaffe ES, Raffeld M. Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood. 1990;76:2086-90.